603168 莎普爱思
已收盘 12-26 15:00:00
资讯
新帖
简况
每周股票复盘：陈德康减持莎普爱思（603168）361.1万股
证券之星 · 03:46
每周股票复盘：陈德康减持莎普爱思（603168）361.1万股
莎普爱思（603168）披露股东减持股份结果公告，12月25日股价上涨0.39%
证券之星 · 12-25 22:59
莎普爱思（603168）披露股东减持股份结果公告，12月25日股价上涨0.39%
12月4日莎普爱思发布公告，股东减持321.1万股
证券之星 · 12-04
12月4日莎普爱思发布公告，股东减持321.1万股
每周股票复盘：莎普爱思（603168）修订公司章程获高票通过
证券之星 · 11-23
每周股票复盘：莎普爱思（603168）修订公司章程获高票通过
莎普爱思（603168）披露修订《公司章程》议案获股东会通过，11月19日股价下跌2.16%
证券之星 · 11-19
莎普爱思（603168）披露修订《公司章程》议案获股东会通过，11月19日股价下跌2.16%
每周股票复盘：莎普爱思（603168）获新药临床试验批准
证券之星 · 11-16
每周股票复盘：莎普爱思（603168）获新药临床试验批准
莎普爱思(603168.SH)获得去氧肾上腺素酮咯酸溶液临床试验批准通知书
智通财经 · 11-14
莎普爱思(603168.SH)获得去氧肾上腺素酮咯酸溶液临床试验批准通知书
莎普爱思（603168）披露拟回购注销部分限制性股票公告，11月13日股价上涨1.69%
证券之星 · 11-13
莎普爱思（603168）披露拟回购注销部分限制性股票公告，11月13日股价上涨1.69%
莎普爱思（603168）披露举办2025年三季度业绩说明会的公告，11月11日股价上涨0.48%
证券之星 · 11-11
莎普爱思（603168）披露举办2025年三季度业绩说明会的公告，11月11日股价上涨0.48%
每周股票复盘：莎普爱思（603168）4992万股限售股将上市
证券之星 · 11-09
每周股票复盘：莎普爱思（603168）4992万股限售股将上市
莎普爱思（603168）披露向特定对象发行股票限售股上市流通公告，11月03日股价上涨0.62%
证券之星 · 11-03
莎普爱思（603168）披露向特定对象发行股票限售股上市流通公告，11月03日股价上涨0.62%
每周股票复盘：莎普爱思（603168）Q3净利增195.54%
证券之星 · 11-02
每周股票复盘：莎普爱思（603168）Q3净利增195.54%
莎普爱思（603168）：三季度净利润盈利576.94万元
同壁财经 · 10-31
莎普爱思（603168）：三季度净利润盈利576.94万元
图解莎普爱思三季报：第三季度单季净利润同比增长195.54%
证券之星 · 10-30
图解莎普爱思三季报：第三季度单季净利润同比增长195.54%
莎普爱思（603168）披露拟修订公司章程公告，10月30日股价下跌0.5%
证券之星 · 10-30
莎普爱思（603168）披露拟修订公司章程公告，10月30日股价下跌0.5%
每周股票复盘：莎普爱思（603168）拟注销179.85万股限制性股票
证券之星 · 10-19
每周股票复盘：莎普爱思（603168）拟注销179.85万股限制性股票
莎普爱思（603168）披露2023年股票期权与限制性股票激励计划部分限制性股票回购注销实施公告，10月15日股价上涨1.71%
证券之星 · 10-15
莎普爱思（603168）披露2023年股票期权与限制性股票激励计划部分限制性股票回购注销实施公告，10月15日股价上涨1.71%
每周股票复盘：莎普爱思（603168）股东拟减持不超3%股份
证券之星 · 09-28
每周股票复盘：莎普爱思（603168）股东拟减持不超3%股份
9月26日增减持汇总：莎普爱思等12家公司减持 当日暂无A股增持（表）
新浪证券 · 09-26
9月26日增减持汇总：莎普爱思等12家公司减持 当日暂无A股增持（表）
莎普爱思(603168.SH)：上海景兴拟减持不超3%股份
智通财经网 · 09-26
莎普爱思(603168.SH)：上海景兴拟减持不超3%股份
加载更多
公司概况
公司名称：
浙江莎普爱思药业股份有限公司
所属行业：
医药制造业
上市日期：
2014-07-02
主营业务：
浙江莎普爱思药业股份有限公司的主营业务是药品研发、生产、销售及医疗服务。公司的主要产品是滴眼液、大输液、头孢克肟、诊疗服务。公司于2024年被授予科技进步先进单位及创新赋能奖荣誉。
发行价格：
21.85
{"stockData":{"symbol":"603168","market":"SH","secType":"STK","nameCN":"莎普爱思","latestPrice":7.53,"timestamp":1766732401000,"preClose":7.67,"halted":0,"volume":5235100,"delay":0,"changeRate":-0.0183,"floatShares":373000000,"shares":374000000,"eps":-0.1739,"marketStatus":"已收盘","change":-0.14,"latestTime":"12-26 15:00:00","open":7.65,"high":7.67,"low":7.51,"amount":39713000,"amplitude":0.0209,"askPrice":7.54,"askSize":596,"bidPrice":7.53,"bidSize":308,"shortable":0,"etf":0,"ttmEps":-0.1739,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766971800000},"marketStatusCode":5,"adr":0,"adjPreClose":7.67,"symbolType":"stock","openAndCloseTimeList":[[1766712600000,1766719800000],[1766725200000,1766732400000]],"highLimit":8.44,"lowLimit":6.9,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":374126505,"isCdr":false,"pbRate":1.74,"roa":"--","roe":"1.72%","epsLYR":-0.33,"committee":0.373836,"marketValue":2817000000,"turnoverRate":0.0141,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-12-29。","floatMarketCap":2805000000},"requestUrl":"/m/hq/s/603168","defaultTab":"news","newsList":[{"id":"2594242634","title":"每周股票复盘：陈德康减持莎普爱思（603168）361.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2594242634","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594242634?lang=zh_cn&edition=full","pubTime":"2025-12-28 03:46","pubTimestamp":1766864771,"startTime":"0","endTime":"0","summary":"截至2025年12月26日收盘，莎普爱思报收于7.53元，较上周的7.74元下跌2.71%。本周，莎普爱思12月22日盘中最高价报7.85元。本周关注点股本股东变化：股东陈德康减持361.1万股，占总股本0.91%。股本股东变化股东增减持12月25日莎普爱思发布公告，股东陈德康于2025年12月4日至12月24日合计减持40.0万股，占公司目前总股本的0.1069%。减持后，陈德康持有公司股份40,260,004股，占当前总股本的10.76%。公司总股本因限制性股票回购注销减少至374,126,505股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122800000860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2594230578","title":"莎普爱思（603168）披露股东减持股份结果公告，12月25日股价上涨0.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594230578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594230578?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:59","pubTimestamp":1766674754,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，莎普爱思报收于7.67元，较前一交易日上涨0.39%，最新总市值为28.7亿元。公司近日发布公告称，浙江莎普爱思药业股份有限公司股东陈德康在2025年9月25日至12月24日期间，通过集中竞价交易方式减持公司股份3,611,000股，占公司总股本的0.91%，减持价格区间为8.10～8.52元/股，减持总金额30,171,459元。减持后，陈德康持有公司股份40,260,004股，占当前总股本的10.76%。公司总股本因限制性股票回购注销减少至374,126,505股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036557.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2588002759","title":"12月4日莎普爱思发布公告，股东减持321.1万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2588002759","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588002759?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:01","pubTimestamp":1764838870,"startTime":"0","endTime":"0","summary":"证券之星消息，12月4日莎普爱思发布公告《莎普爱思:莎普爱思关于持股5%以上股东权益变动触及1%刻度的提示性公告》，其股东陈德康于2025年7月9日至2025年12月3日间合计减持321.1万股，占公司目前总股本的0.8583%，变动期间该股股价上涨6.96%，截止12月3日收盘报8.3元。股东增减持详情见下表：根据莎普爱思2025年三季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400025607.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2585210519","title":"每周股票复盘：莎普爱思（603168）修订公司章程获高票通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2585210519","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585210519?lang=zh_cn&edition=full","pubTime":"2025-11-23 03:52","pubTimestamp":1763841133,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，莎普爱思报收于7.62元，较上周的8.48元下跌10.14%。本周，莎普爱思11月17日盘中最高价报8.55元。莎普爱思当前最新总市值28.51亿元，在化学制药板块市值排名136/151，在两市A股市值排名4584/5167。本周关注点公司公告汇总：莎普爱思2025年第二次临时股东会审议通过修订《公司章程》议案，同意股份数占出席会议股东所持表决权的99.8454%。出席会议的股东及代理人共145人，代表有表决权股份总数的26.0488%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2584947549","title":"莎普爱思（603168）披露修订《公司章程》议案获股东会通过，11月19日股价下跌2.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584947549","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584947549?lang=zh_cn&edition=full","pubTime":"2025-11-19 22:27","pubTimestamp":1763562441,"startTime":"0","endTime":"0","summary":"截至2025年11月19日收盘，莎普爱思报收于8.16元，较前一交易日下跌2.16%，最新总市值为30.53亿元。该股当日开盘8.34元，最高8.37元，最低8.1元，成交额达4604.93万元，换手率为1.51%。公司近日发布公告称，浙江莎普爱思药业股份有限公司于2025年11月19日召开2025年第二次临时股东会，审议通过了关于修订《公司章程》的议案。出席会议的股东及代理人共145人，代表有表决权股份总数的26.0488%。议案为特别决议事项，已获得出席股东所持表决权三分之二以上通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111900040085.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2583541836","title":"每周股票复盘：莎普爱思（603168）获新药临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2583541836","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583541836?lang=zh_cn&edition=full","pubTime":"2025-11-16 04:53","pubTimestamp":1763239987,"startTime":"0","endTime":"0","summary":"截至2025年11月14日收盘，莎普爱思报收于8.48元，较上周的8.08元上涨4.95%。本周，莎普爱思11月14日盘中最高价报8.55元。本周关注点公司公告汇总：莎普爱思获去氧肾上腺素酮咯酸溶液临床试验批准。莎普爱思关于召开2025年第二次临时股东会的提示性公告浙江莎普爱思药业股份有限公司将于2025年11月19日召开2025年第二次临时股东会，会议由董事会召集，采取现场投票与网络投票相结合方式。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600001452.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2583224573","title":"莎普爱思(603168.SH)获得去氧肾上腺素酮咯酸溶液临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2583224573","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583224573?lang=zh_cn&edition=full","pubTime":"2025-11-14 16:31","pubTimestamp":1763109104,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)发布公告，近日，公司获得国家药品监督管理局核准签发的关于去氧肾上腺素酮咯酸溶液的《药物临床试验批准通知书》(通知书编号：2025LP03018)，公司拟于条件具备后开展临床试验。该药品主要适用于白内障手术或人工晶状体置换手术过程中维持散瞳，防止手术中瞳孔缩小并且缓解术后眼部疼痛。截至公告披露日，去氧肾上腺素酮咯酸溶液项目累计研发投入约555.63万元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1369298.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2583568925","title":"莎普爱思（603168）披露拟回购注销部分限制性股票公告，11月13日股价上涨1.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2583568925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583568925?lang=zh_cn&edition=full","pubTime":"2025-11-13 17:33","pubTimestamp":1763026421,"startTime":"0","endTime":"0","summary":"截至2025年11月13日收盘，莎普爱思报收于8.42元，较前一交易日上涨1.69%，最新总市值为31.5亿元。近日，莎普爱思发布《2025年第二次临时股东会会议资料》公告，称因2023年股票期权与限制性股票激励计划中部分激励对象离职及2024年度公司层面业绩考核不达标，公司拟回购注销限制性股票1,798,500股。本次回购注销完成后，公司股份总数将由375,925,005股变更为374,126,505股，注册资本相应由375,925,005元变更为374,126,505元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111300030409.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2582354223","title":"莎普爱思（603168）披露举办2025年三季度业绩说明会的公告，11月11日股价上涨0.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582354223","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582354223?lang=zh_cn&edition=full","pubTime":"2025-11-11 17:26","pubTimestamp":1762853198,"startTime":"0","endTime":"0","summary":"截至2025年11月11日收盘，莎普爱思报收于8.29元，较前一交易日上涨0.48%，最新总市值为31.02亿元。该股当日开盘8.24元，最高8.33元，最低8.16元，成交额达6994.42万元，换手率为2.27%。公司近日发布公告称，浙江莎普爱思药业股份有限公司将于2025年11月18日15:30-16:30通过网络互动方式在价值在线平台举行2025年三季度业绩说明会，介绍公司经营业绩、发展战略等情况。投资者可提前通过指定链接或小程序提问，说明会后可通过平台查看会议内容。公司已披露2025年三季度报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111100028262.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2582861620","title":"每周股票复盘：莎普爱思（603168）4992万股限售股将上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2582861620","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582861620?lang=zh_cn&edition=full","pubTime":"2025-11-09 03:53","pubTimestamp":1762631591,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：莎普爱思49,921,506股限售股将于2025年11月10日上市流通公司公告汇总申万宏源证券承销保荐有限责任公司对莎普爱思非公开发行股票限售股上市流通事项出具核查意见，确认本次49,921,506股限售股上市流通符合相关法规要求，信息披露真实准确完整，无异议。莎普爱思发布关于向特定对象发行股票限售股上市流通的公告，本次上市流通的限售股数量为49,921,506股，上市流通日期为2025年11月10日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001394.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2580214921","title":"莎普爱思（603168）披露向特定对象发行股票限售股上市流通公告，11月03日股价上涨0.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580214921","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580214921?lang=zh_cn&edition=full","pubTime":"2025-11-03 22:43","pubTimestamp":1762180997,"startTime":"0","endTime":"0","summary":"截至2025年11月3日收盘，莎普爱思报收于8.05元，较前一交易日上涨0.62%，最新总市值为30.12亿元。公司近日发布公告称，浙江莎普爱思药业股份有限公司非公开发行股票限售股即将上市流通，上市股数为49,921,506股，上市流通日期为2025年11月10日。本次限售股为非公开发行股份，涉及发行对象上海养和实业有限公司和林弘远，分别认购47,095,761股和2,825,745股，限售期均为36个月。截至公告日，相关股东已严格履行股份锁定承诺。保荐机构对公司本次限售股上市流通无异议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110300036335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2580470144","title":"每周股票复盘：莎普爱思（603168）Q3净利增195.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580470144","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580470144?lang=zh_cn&edition=full","pubTime":"2025-11-02 08:18","pubTimestamp":1762042699,"startTime":"0","endTime":"0","summary":"本周关注点来自业绩披露要点：莎普爱思2025年第三季度归母净利润576.94万元，同比上升195.54%。来自公司公告汇总：莎普爱思将于2025年11月19日召开第二次临时股东会，审议修订公司章程议案。股本股东变化截至2025年9月30日，莎普爱思股东户数为2.83万户，较6月30日增加670户，增幅2.43%。业绩披露要点莎普爱思2025年三季报显示，前三季度实现主营收入3.51亿元，同比下降2.44%；归母净利润2763.22万元，同比增长189.85%；扣非净利润431.97万元，同比增长108.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2579003460","title":"莎普爱思（603168）：三季度净利润盈利576.94万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579003460","media":"同壁财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579003460?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:47","pubTimestamp":1761918420,"startTime":"0","endTime":"0","summary":"今年前三季度，莎普爱思实现营业收入3.51亿元，同比下降2.44%；归母净利润2763.22万元，同比；扣非归母净利润431.97万元，同比。同壁财经小贴士：目前公司属于医疗保健行业，主要产品类型为原料药，2024年报主营构成为滴眼液:38.77%;诊疗服务:31.81%;头孢克肟:15.51%;其他:8.28%;大输液:3.19%;其他业务:2.45%。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-31/doc-infvuxsp5503828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["603168"],"gpt_icon":0},{"id":"2579148244","title":"图解莎普爱思三季报：第三季度单季净利润同比增长195.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579148244","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579148244?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:28","pubTimestamp":1761823717,"startTime":"0","endTime":"0","summary":"证券之星消息，莎普爱思2025年三季报显示，前三季度公司主营收入3.51亿元，同比下降2.44%；归母净利润2763.22万元，同比上升189.85%；扣非净利润431.97万元，同比上升108.6%；其中2025年第三季度，公司单季度主营收入1.15亿元，同比下降6.54%；单季度归母净利润576.94万元，同比上升195.54%；单季度扣非净利润-1736.46万元，同比上升30.94%；负债率24.08%，投资收益2286.4万元，财务费用724.77万元，毛利率53.6%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000039958.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168"],"gpt_icon":0},{"id":"2579116407","title":"莎普爱思（603168）披露拟修订公司章程公告，10月30日股价下跌0.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579116407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579116407?lang=zh_cn&edition=full","pubTime":"2025-10-30 18:08","pubTimestamp":1761818882,"startTime":"0","endTime":"0","summary":"截至2025年10月30日收盘，莎普爱思报收于8.01元，较前一交易日下跌0.5%，最新总市值为29.97亿元。该股当日开盘8.01元，最高8.09元，最低7.93元，成交额达4691.23万元，换手率为1.81%。公司近日发布公告称，浙江莎普爱思药业股份有限公司将于2025年11月19日召开2025年第二次临时股东会，会议将采取现场投票与网络投票相结合的方式进行。现场会议定于当日10:00在浙江省平湖市经济开发区新明路1588号公司办公楼五楼董事会会议室召开。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000035931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2576049618","title":"每周股票复盘：莎普爱思（603168）拟注销179.85万股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2576049618","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576049618?lang=zh_cn&edition=full","pubTime":"2025-10-19 03:32","pubTimestamp":1760815930,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，莎普爱思报收于7.71元，较上周的7.7元上涨0.13%。本周，莎普爱思10月17日盘中最高价报7.89元。本周关注点公司公告汇总：莎普爱思因激励对象离职及业绩考核不达标，拟回购注销1,798,500股限制性股票。股份注销日期为2025年10月20日，注销后公司总股本将由375,925,005股变更为374,126,505股。上海君澜律师事务所出具法律意见书，认为本次回购注销符合相关法律法规及激励计划规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900000697.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2575736638","title":"莎普爱思（603168）披露2023年股票期权与限制性股票激励计划部分限制性股票回购注销实施公告，10月15日股价上涨1.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575736638","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575736638?lang=zh_cn&edition=full","pubTime":"2025-10-15 22:38","pubTimestamp":1760539093,"startTime":"0","endTime":"0","summary":"截至2025年10月15日收盘，莎普爱思报收于7.72元，较前一交易日上涨1.71%，最新总市值为29.02亿元。近日，浙江莎普爱思药业股份有限公司发布《莎普爱思2023年股票期权与限制性股票激励计划部分限制性股票回购注销实施公告》。相关股份已提交中国证券登记结算有限责任公司上海分公司申请注销，预计于2025年10月20日完成。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101500038431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603168","BK0239"],"gpt_icon":0},{"id":"2570894027","title":"每周股票复盘：莎普爱思（603168）股东拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2570894027","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570894027?lang=zh_cn&edition=full","pubTime":"2025-09-28 04:16","pubTimestamp":1759004172,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，莎普爱思报收于7.78元，较上周的8.47元下跌8.15%。本周，莎普爱思9月24日盘中最高价报8.48元。本周关注点公司公告汇总：上海景兴计划合计减持莎普爱思不超过总股本3.0000%的股份。上海景兴实业投资有限公司持有公司无限售条件流通股12,982,726股，占总股本的3.4535%。因资金需求，上海景兴计划通过集中竞价交易方式减持不超过3,759,250股，通过大宗交易方式减持不超过7,518,500股，合计减持不超过11,277,750股。股东此前承诺与本次减持一致。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800001088.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603168"],"gpt_icon":0},{"id":"2570449886","title":"9月26日增减持汇总：莎普爱思等12家公司减持 当日暂无A股增持（表）","url":"https://stock-news.laohu8.com/highlight/detail?id=2570449886","media":"新浪证券","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570449886?lang=zh_cn&edition=full","pubTime":"2025-09-26 20:53","pubTimestamp":1758891180,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 据统计，9月26日，截至发稿，盘后长芯博创、跃岭股份、闻泰科技（维权）、合合信息、易点天下、风语筑、天岳先进、奥瑞德、再升科技、绿岛风、莎普爱思、沃尔德等12家上市公司披露减持情况。当日暂无上市公司披露增持情况。\n\n新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2025-09-26/doc-infrvstm6344162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","159982","603168","399300"],"gpt_icon":0},{"id":"2570100524","title":"莎普爱思(603168.SH)：上海景兴拟减持不超3%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2570100524","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570100524?lang=zh_cn&edition=full","pubTime":"2025-09-26 17:07","pubTimestamp":1758877666,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莎普爱思(603168.SH)发布公告，上海景兴因资金需求，计划自公告披露之日起3个交易日后的3个月内，即2025年10月10日至2026年1月9日，减持公司股份数量合计不超过1127.78万股，即不超过公司总股本的3%。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1349890.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["603168","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766917363747,"stockEarnings":[{"period":"1week","weight":-0.0271},{"period":"1month","weight":-0.0528},{"period":"3month","weight":-0.0321},{"period":"6month","weight":0.0273},{"period":"1year","weight":0.0913},{"period":"ytd","weight":0.1239}],"compareEarnings":[{"period":"1week","weight":0.0188},{"period":"1month","weight":0.0257},{"period":"3month","weight":0.0354},{"period":"6month","weight":0.1575},{"period":"1year","weight":0.1664},{"period":"ytd","weight":0.1826}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江莎普爱思药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"28285人(较上一季度增加2.43%)","perCapita":"13170股","listingDate":"2014-07-02","address":"浙江省嘉兴市平湖市经济开发区新明路1588号","registeredCapital":"37412万元","survey":" 浙江莎普爱思药业股份有限公司的主营业务是药品研发、生产、销售及医疗服务。公司的主要产品是滴眼液、大输液、头孢克肟、诊疗服务。公司于2024年被授予科技进步先进单位及创新赋能奖荣誉。","listedPrice":21.85},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"莎普爱思,603168,莎普爱思股票,莎普爱思股票老虎,莎普爱思股票老虎国际,莎普爱思行情,莎普爱思股票行情,莎普爱思股价,莎普爱思股市,莎普爱思股票价格,莎普爱思股票交易,莎普爱思股票购买,莎普爱思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"莎普爱思(603168)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供莎普爱思(603168)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}